Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30602603 | 0.88 | CA2 (0.36) | DDAH1MEN1KMT2A | |
| SCHEMBL559406 | 0.84 | ALOX15 (0.46) | ALOX15MEN1CYP1A2KMT2AALDH1A1 | |
| SCHEMBL1664818 | 0.81 | ALDH1A1 (0.34) | DDAH1ALDH1A1 | |
| SCHEMBL29110828 | 0.79 | GAA (0.34) | ALOX15KMT2AALDH1A1GAARAB9A | |
| SCHEMBL6934423 | 0.76 | ALDH1A1 (0.32) | DDAH1ALDH1A1 | |
| SCHEMBL7367907 | 0.75 | DDAH1 (0.33) | ALOX15DDAH1 | |
| SCHEMBL10702225 | 0.74 | DDAH1 (0.38) | DDAH1ALDH1A1 | |
| Isobutyramide SCHEMBL28185255 | 0.72 | ALDH1A1 (0.36) | ALOX15DDAH1ALDH1A1 | |
| SCHEMBL27789246 | 0.71 | — | — | |
| SCHEMBL4283583 | 0.71 | LMNA (0.39) | ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090192192-A1 | INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA | TOUCH BIONICS LIMITED (GB) | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192192-A1 | INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA | PGLS, TFPI, Q6ZSR9 | ALOX15 3970/4885DDAH1 2179/4885MEN1 4659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.